
Palisade Bio, Inc.
PALIHealthcare|Biotechnology|US
$1.13
-0.03 (-2.59%)
DCF Value
$2.39
Tangible Book / Share
$0.58
Cash / Share
$0.59
Ownership Breakdown
92.2%
Float
174.3M
Shares Outstanding
160.7M
Float Shares
Major Holders (33)
Combined: 209.8%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | IA, HC | 9.99% | 14,885,421 | Dec 8, 2025 | 13D/G |
| Steven Boyd | HC, IN | 9.99% | 471,906 | May 15, 2025 | 13D/G |
| Armistice Capital, LLC | IA, OO | 9.99% | 471,906 | May 15, 2025 | 13D/G |
| RA Capital Management, L.P. | IA, PN | 9.90% | 17,620,479 | May 15, 2026 | 13D/G |
| Peter Kolchinsky | HC, IN | 9.90% | 17,620,479 | May 15, 2026 | 13D/G |
| Rajeev Shah | HC, IN | 9.90% | 17,620,479 | May 15, 2026 | 13D/G |
| RA Capital Healthcare Fund, L.P. | Partnership | 9.90% | 17,620,479 | May 15, 2026 | 13D/G |
| Joseph Edelman | Individual | 7.90% | 14,113,863 | May 15, 2026 | 13D/G |
| Perceptive Life Sciences Master Fund, Ltd. | Corporation | 7.90% | 14,113,863 | May 15, 2026 | 13D/G |
| Perceptive Advisors LLC | Investment adviser | 7.90% | 14,113,863 | May 15, 2026 | 13D/G |
| Soleus Capital Group, LLC | Other | 7.50% | 13,063,687 | Aug 13, 2026 | 13D/G |
| Soleus GP, LLC | Other | 7.50% | 13,063,687 | Aug 13, 2026 | 13D/G |
| Guy Levy | Individual | 7.50% | 13,063,687 | Aug 13, 2026 | 13D/G |
| Soleus Capital Master Fund, L.P. | Non-US institution | 7.50% | 13,063,687 | Aug 13, 2026 | 13D/G |
| Soleus Capital Management, L.P. | Partnership | 7.50% | 13,063,687 | Aug 13, 2026 | 13D/G |
| Soleus Capital, LLC | Other | 7.50% | 13,063,687 | Aug 13, 2026 | 13D/G |
| Ting Jia | HC, IN | 6.40% | 9,567,898 | Feb 10, 2026 | 13D/G |
| Octagon Capital Advisors LP | IA, PN | 6.40% | 9,567,898 | Feb 10, 2026 | 13D/G |
| Octagon Investments Master Fund LP | PN, OO | 6.40% | 9,567,898 | Feb 10, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 6.00% | 10,436,760 | Jul 29, 2026 | 13D/G |
| Franklin Resources, Inc. | HC, CO | 6.00% | 9,163,990 | Jan 29, 2026 | 13D/G |
| Franklin Advisers, Inc. | IA, CO | 6.00% | 9,163,990 | Jan 29, 2026 | 13D/G |
| Janus Henderson Biotech Innovation Master Fund Ltd | Investment company | 6.00% | 8,897,507 | Dec 8, 2025 | 13D/G |
| Ameriprise Financial, Inc. | Holding company | 5.30% | 8,711,385 | May 15, 2026 | 13D/G |
| Columbia Management Investment Advisers, LLC | Investment adviser | 5.30% | 8,711,385 | May 15, 2026 | 13D/G |
| Vanguard Capital Management | Investment adviser | 5.16% | 8,995,805 | Oct 30, 2026 | 13D/G |
| William Blank | HC, IN | 3.00% | 4,500,000 | Feb 17, 2026 | 13D/G |
| Matthew Sesterhenn | HC, IN | 3.00% | 4,500,000 | Feb 17, 2026 | 13D/G |
| Squadron Capital Management LLC | IA, HC | 3.00% | 4,500,000 | Feb 17, 2026 | 13D/G |
| Squadron Master Fund LP | Partnership | 3.00% | 4,500,000 | Feb 17, 2026 | 13D/G |
| Point72 Capital Advisors, Inc. | Corporation | 0.20% | 411,772 | May 15, 2026 | 13D/G |
| Steven A. Cohen | Individual | 0.20% | 411,772 | May 15, 2026 | 13D/G |
| Point72 Asset Management, L.P. | Partnership | 0.20% | 411,772 | May 15, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 13,623,108 acquired · 9,173,147 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Capers Julien E. | See Remarks | Oct 19, 2026 | AWARD | 787,300 | — | — | Form 4 |
| Capers Julien E. | officer | Oct 19, 2026 | OTHER | 0 | — | — | Form 4 |
| Jones Mitchell Lawrence | See Remarks | Oct 6, 2026 | OPTION EX. | 2,555,266 | — | — | Form 4 |
| Jones Mitchell Lawrence | See Remarks | Oct 6, 2026 | OPTION EX. | 2,620,850 | — | — | Form 4 |
| Jones Mitchell Lawrence | See Remarks | Oct 6, 2026 | TAX W/H | 1,031,102 | $1.49 | $1.5M | Form 4 |
| Jones Mitchell Lawrence | See Remarks | Oct 6, 2026 | OPTION EX. | 65,584 | — | — | Form 4 |
| Finley John David | director, officer: CEO CFO | Oct 6, 2026 | OPTION EX. | 3,059,800 | — | — | Form 4 |
| Finley John David | director, officer: CEO CFO | Oct 6, 2026 | OPTION EX. | 3,227,384 | — | — | Form 4 |
| Finley John David | director, officer: CEO CFO | Oct 6, 2026 | TAX W/H | 1,411,982 | $1.49 | $2.1M | Form 4 |
| Finley John David | director, officer: CEO CFO | Oct 6, 2026 | OPTION EX. | 167,584 | — | — | Form 4 |
| Williams Donald Allen | director | Oct 2, 2026 | BUY | 10,000 | $1.46 | $14.6K | Form 4 |
| Williams Donald Allen | director | Oct 1, 2026 | BUY | 10,000 | $1.42 | $14.2K | Form 4 |
| Finley John David | director, officer: CEO, CFO | Aug 19, 2026 | GIFT | 88,400 | — | — | Form 4 |
| Finley John David | director, officer: CEO, CFO | Aug 19, 2026 | GIFT | 88,400 | — | — | Form 4 |
| Baltera Robert Jr. | director | Jul 9, 2026 | BUY | 25,000 | $1.96 | $48.9K | Form 4 |
| Baltera Robert Jr. | director | Jul 8, 2026 | BUY | 20,000 | $1.99 | $39.8K | Form 4 |
| Baltera Robert Jr. | director | Jul 7, 2026 | BUY | 30,000 | $2.03 | $61.0K | Form 4 |
| Baltera Robert Jr. | director | Jul 6, 2026 | BUY | 20,000 | $2.05 | $41.0K | Form 4 |
| Jones Mitchell Lawrence | Chief Medical Officer | Jul 6, 2026 | OPTION EX. | 131,167 | — | — | Form 4 |
| Jones Mitchell Lawrence | Chief Medical Officer | Jul 6, 2026 | OPTION EX. | 131,167 | — | — | Form 4 |
| Jones Mitchell Lawrence | Chief Medical Officer | Jul 7, 2026 | SELL | 51,880 | $2.05 | $106.5K | Form 4 |
| Finley John David | director, officer: CEO, CFO | Jul 6, 2026 | OPTION EX. | 335,167 | — | — | Form 4 |
| Finley John David | director, officer: CEO, CFO | Jul 6, 2026 | OPTION EX. | 335,167 | — | — | Form 4 |
| Finley John David | director, officer: CEO, CFO | Jul 7, 2026 | OPTION EX. | 133 | $0.70 | $93.10 | Form 4 |
| Finley John David | director, officer: CEO, CFO | Jul 7, 2026 | SELL | 146,798 | $2.07 | $303.3K | Form 4 |
| Finley John David | director, officer: CEO, CFO | Jul 7, 2026 | OPTION EX. | 133 | $0.70 | $93.10 | Form 4 |
| Baltera Robert Jr. | director | Jul 2, 2026 | BUY | 10,000 | $1.98 | $19.8K | Form 4 |
| Baltera Robert Jr. | director | Jul 1, 2026 | BUY | 20,000 | $1.98 | $39.6K | Form 4 |
| Baltera Robert Jr. | director | Jun 10, 2026 | AWARD | 336,904 | — | — | Form 4 |
| Baltera Robert Jr. | director: | Jun 10, 2026 | OTHER | 0 | — | — | Form 4 |
| Wei Binxian | director | Jun 10, 2026 | OPTION EX. | 20,200 | — | — | Form 4 |
| Wei Binxian | director | Jun 10, 2026 | AWARD | 592,300 | — | — | Form 4 |
| Wei Binxian | director | Jun 10, 2026 | OPTION EX. | 20,200 | — | — | Form 4 |
| Williams Donald Allen | director | Jun 10, 2026 | OPTION EX. | 60,666 | — | — | Form 4 |
| Williams Donald Allen | director | Jun 10, 2026 | AWARD | 1,498,900 | — | — | Form 4 |
| Williams Donald Allen | director | Jun 10, 2026 | OPTION EX. | 60,666 | — | — | Form 4 |
| Chuang Emil | director | Jun 10, 2026 | OPTION EX. | 20,200 | — | — | Form 4 |
| Chuang Emil | director | Jun 10, 2026 | AWARD | 592,300 | — | — | Form 4 |
| Chuang Emil | director | Jun 10, 2026 | OPTION EX. | 20,200 | — | — | Form 4 |
| Zwick Jordan Michael | director | Jun 10, 2026 | AWARD | 336,904 | — | — | Form 4 |
| Zwick Jordan Michael | director: | Jun 10, 2026 | OTHER | 0 | — | — | Form 4 |
| Jones Mitchell Lawrence | Chief Medical Officer | Feb 11, 2026 | OPTION EX. | 8,000 | — | — | Form 4 |
| Jones Mitchell Lawrence | Chief Medical Officer | Feb 11, 2026 | OPTION EX. | 8,000 | — | — | Form 4 |
| Jones Mitchell Lawrence | Chief Medical Officer | Feb 12, 2026 | SELL | 1,989 | $1.75 | $3.5K | Form 4 |
| Finley John David | director, officer: CEO, CFO | Feb 11, 2026 | OPTION EX. | 13,333 | — | — | Form 4 |
| Finley John David | director, officer: CEO, CFO | Feb 12, 2026 | SELL | 3,896 | $1.75 | $6.8K | Form 4 |
| Finley John David | director, officer: CEO, CFO | Feb 11, 2026 | OPTION EX. | 13,333 | — | — | Form 4 |
| Jones Mitchell Lawrence | Chief Medical Officer | Feb 9, 2026 | AWARD | 787,000 | — | — | Form 4 |
| Finley John David | director, officer: CEO, CFO | Feb 9, 2026 | AWARD | 2,011,000 | — | — | Form 4 |
| Williams Donald Allen | director | Jan 16, 2026 | BUY | 5,000 | $1.67 | $8.4K | Form 4 |
| Williams Donald Allen | director | Jan 9, 2026 | BUY | 5,000 | $1.88 | $9.4K | Form 4 |
| Williams Donald Allen | director | Oct 6, 2025 | AWARD | 182,000 | — | — | Form 4 |
| Wei Binxian | director | Oct 6, 2025 | AWARD | 60,600 | — | — | Form 4 |
| Chuang Emil | director | Oct 6, 2025 | AWARD | 60,600 | — | — | Form 4 |
| Williams Donald Allen | director | Oct 6, 2025 | AWARD | 1,538,700 | — | — | Form 4 |
| Wei Binxian | director | Oct 6, 2025 | AWARD | 510,700 | — | — | Form 4 |
| Jones Mitchell Lawrence | Chief Medical Officer | Oct 6, 2025 | AWARD | 7,665,800 | — | — | Form 4 |
| Finley John David | director, officer: CEO, CFO | Oct 6, 2025 | AWARD | 9,179,400 | — | — | Form 4 |
| Chuang Emil | director | Oct 6, 2025 | AWARD | 510,700 | — | — | Form 4 |
| Williams Donald Allen | director | Sep 4, 2025 | AWARD | 64,400 | — | — | Form 4 |
| Finley John David | director, officer: CEO, CFO | Sep 4, 2025 | AWARD | 323,400 | — | — | Form 4 |
| Wei Binxian | director | Sep 4, 2025 | AWARD | 18,800 | — | — | Form 4 |
| Jones Mitchell Lawrence | Chief Medical Officer | Sep 4, 2025 | AWARD | 289,000 | — | — | Form 4 |
| Chuang Emil | director | Sep 4, 2025 | AWARD | 18,800 | — | — | Form 4 |
| Chuang Emil | director: | Jul 7, 2025 | OTHER | 0 | — | — | Form 4 |
| Jones Mitchell Lawrence | Chief Medical Officer | Feb 11, 2025 | AWARD | 29,000 | $1.13 | $32.8K | Form 4 |
| Jones Mitchell Lawrence | Chief Medical Officer | Feb 11, 2025 | AWARD | 24,000 | — | — | Form 4 |
| Finley John David | director, officer: CEO, CFO | Feb 11, 2025 | AWARD | 47,000 | $1.13 | $53.1K | Form 4 |
| Finley John David | director, officer: CEO, CFO | Feb 11, 2025 | AWARD | 40,000 | — | — | Form 4 |
| Wei Binxian | director | Nov 21, 2024 | OPTION EX. | 388 | — | — | Form 4 |
| Williams Donald Allen | director | Nov 21, 2024 | OPTION EX. | 388 | — | — | Form 4 |
| Wei Binxian | director | Jul 11, 2024 | AWARD | 2,100 | $4.49 | $9.4K | Form 4 |
| Fischbein Margery B. | director | Jul 11, 2024 | AWARD | 2,100 | $4.49 | $9.4K | Form 4 |
| Williams Donald Allen | director | Jul 11, 2024 | AWARD | 2,100 | $4.49 | $9.4K | Form 4 |
| Wei Binxian | director | Jun 11, 2024 | OPTION EX. | 465 | — | — | Form 4 |
| Williams Donald Allen | director | Jun 11, 2024 | OPTION EX. | 340 | — | — | Form 4 |
| Jones Mitchell Lawrence | Chief Medical Officer | May 28, 2024 | OPTION EX. | 1,555 | — | — | Form 4 |
| Jones Mitchell Lawrence | Chief Medical Officer | May 28, 2024 | TAX W/H | 461 | $4.76 | $2.2K | Form 4 |
| Jones Mitchell Lawrence | Chief Medical Officer | May 28, 2024 | OPTION EX. | 2,735 | — | — | Form 4 |
| Jones Mitchell Lawrence | Chief Medical Officer | May 28, 2024 | TAX W/H | 810 | $4.76 | $3.9K | Form 4 |
| Jones Mitchell Lawrence | Chief Medical Officer | May 28, 2024 | OPTION EX. | 1,555 | — | — | Form 4 |
| Finley John David | director, officer: CEO, CFO, Director | May 28, 2024 | OPTION EX. | 2,111 | — | — | Form 4 |
| Finley John David | director, officer: CEO, CFO, Director | May 28, 2024 | TAX W/H | 607 | $4.76 | $2.9K | Form 4 |
| Finley John David | director, officer: CEO, CFO, Director | May 28, 2024 | OPTION EX. | 3,335 | — | — | Form 4 |
| Finley John David | director, officer: CEO, CFO, Director | May 28, 2024 | TAX W/H | 959 | $4.76 | $4.6K | Form 4 |
| Finley John David | director, officer: CEO, CFO, Director | May 28, 2024 | OPTION EX. | 1,622 | — | — | Form 4 |
| Finley John David | director, officer: CEO, CFO, Director | May 28, 2024 | TAX W/H | 467 | $4.76 | $2.2K | Form 4 |
| Finley John David | director, officer: CEO, CFO, Director | May 28, 2024 | OPTION EX. | 2,111 | — | — | Form 4 |
| Williams Donald Allen | director | May 28, 2024 | BUY | 1,000 | $4.86 | $4.9K | Form 4 |
| Finley John David | director, officer: CEO, CFO, Director | May 24, 2024 | BUY | 1,000 | $4.81 | $4.8K | Form 4 |
| Finley John David | director, officer: CEO, CFO, Director | May 20, 2024 | AWARD | 666 | $4.97 | $3.3K | Form 4 |
| Fischbein Margery B. | director | May 7, 2024 | DISPOSED | 1,000 | $7.90 | $7.9K | Form 4 |
| Jones Mitchell Lawrence | CEO, CFO, Director | May 6, 2024 | OPTION EX. | 304 | — | — | Form 4 |
| Jones Mitchell Lawrence | CEO, CFO, Director | May 6, 2024 | OPTION EX. | 156 | — | — | Form 4 |
| Jones Mitchell Lawrence | CEO, CFO, Director | May 6, 2024 | OPTION EX. | 156 | — | — | Form 4 |
| Jones Mitchell Lawrence | CEO, CFO, Director | May 6, 2024 | TAX W/H | 47 | $8.46 | $397.62 | Form 4 |
| Jones Mitchell Lawrence | CEO, CFO, Director | May 6, 2024 | OPTION EX. | 304 | — | — | Form 4 |
| Jones Mitchell Lawrence | CEO, CFO, Director | May 6, 2024 | TAX W/H | 90 | $8.46 | $761.40 | Form 4 |
| Finley John David | director, officer: CEO, CFO, Director | May 6, 2024 | OPTION EX. | 211 | — | — | Form 4 |
| Finley John David | director, officer: CEO, CFO, Director | May 6, 2024 | TAX W/H | 61 | $8.46 | $516.06 | Form 4 |